hydralazine has been researched along with cyclic gmp in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (47.83) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamond, J; Janis, RA | 3 |
| Gerzer, R; Heim, JM; Müller, T; Wehling, M; Weil, J; Witzgall, H | 1 |
| Imamura, N; Kurokawa, K; Nakajima, S; Ueda, M | 1 |
| Gerzer, R; Heim, JM; Lorenz, R; Müller, T; Wehling, M; Weil, J; Witzgall, H | 1 |
| Chiou, WF; Liao, CH; Wu, CC; Yen, MH | 1 |
| Hirt, E; Lockette, W; Otsuka, Y | 1 |
| Azuma, H; Ishikawa, M; Mizushima-Kasahara, K; Sekizaki, S | 1 |
| Kreye, VA | 1 |
| Akashi, A; Chiba, T; Hirohashi, M; Suzuki, I; Tanaka, S; Watanabe, K | 1 |
| Fujihara, H; Fujiwara, N; Fukuda, S; Sakuma, K; Shimoji, K; Tanaka, T; Toriumi, T; Tsukui, A | 1 |
| Berkenboom, G; Brékine, D; Fontaine, J; Grosfils, K; Staroukine, M; Unger, P | 1 |
| Calle, A; Jácome, P; López-Jaramillo, P; Narváez, M; Nava, E; Rivera, J; Ruano, C | 1 |
| Goto, K; Kasuya, Y; Kimura, S; Masaki, T; Wei, S; Yanagisawa, M | 1 |
| Anderson, IK; Drew, GM | 1 |
| Kanese, Y; Murakawa, Y; Omata, M; Yamashita, T | 1 |
| Abe, Y; Chen, QH; Kosaka, H; Tian, RX; Yamamoto, A; Yoneyama, H; Zhang, L; Zhou, MS | 1 |
| Alvarez, E; Fernández, G; Medina, M; Orallo, F; Vidrio, H | 1 |
| Alcaide, C; Alvarez, E; González-Romo, P; Orallo, F; Vidrio, H | 1 |
| Pandey, KN; Somanna, N; Vellaichamy, E; Zhao, D | 1 |
| Ajiki, K; Hayami, N; Inaba, H; Kunishima, T; Murakawa, Y; Sugishita, Y; Yamagishi, N; Yamagishi, S | 1 |
| d'Uscio, LV; Kang, KT; Katusic, ZS; Pollock, JS; Spradley, FT; Sullivan, JC | 1 |
1 review(s) available for hydralazine and cyclic gmp
| Article | Year |
|---|---|
Direct vasodilators with unknown modes of action: the nitro-compounds and hydralazine.
Topics: Animals; Calcium; Cell Membrane; Cyclic GMP; Humans; Hydralazine; Muscle Contraction; Muscle Proteins; Nitro Compounds; Nitroglycerin; Nitroprusside; Nitroso Compounds; Sodium Nitrite; Vasodilator Agents | 1984 |
22 other study(ies) available for hydralazine and cyclic gmp
| Article | Year |
|---|---|
Increases in cyclic GMP levels may not mediate relaxant effects of sodium nitroprusside, verapamil and hydralazine in rat vas deferens.
Topics: Animals; Cyclic GMP; Hydralazine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nitroprusside; Phenylephrine; Rats; Vas Deferens; Verapamil | 1978 |
Relationship between cyclic nucleotide levels and drug-induced relaxation of smooth muscle.
Topics: Animals; Cyclic AMP; Cyclic GMP; Diazoxide; Drug Interactions; Female; Guinea Pigs; Hydralazine; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nitroprusside; Verapamil | 1979 |
Effects of clonidine and dihydralazine on plasma ANF and cyclic GMP levels in humans during volume loading.
Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Clonidine; Cyclic GMP; Dihydralazine; Heart Rate; Hematocrit; Humans; Hydralazine; Infusions, Intravenous; Isotonic Solutions; Male; Potassium; Sodium; Sodium Chloride | 1987 |
A study on the hypotensive mechanism of pinacidil: relationship between its vasodilating effect and intracellular Ca2+ levels.
Topics: Animals; Antihypertensive Agents; Calcium; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Guanidines; Guinea Pigs; Hydralazine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Pinacidil; Rabbits; Sulfonamides; Trifluoperazine; Vasodilation | 1989 |
Effects of clonidine and dihydralazine on atrial natriuretic factor and cGMP in humans.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Clonidine; Cyclic GMP; Dihydralazine; Diuresis; Hemodynamics; Humans; Hydralazine; Male; Natriuresis; Renin | 1989 |
Effects of hydralazine on guanosine cyclic 3', 5'-monophosphate levels in rat aorta.
Topics: Animals; Aorta; Biological Transport; Calcium; Cyclic GMP; Endothelium, Vascular; Female; Guanylate Cyclase; Hydralazine; Male; Methylene Blue; Norepinephrine; Potassium; Rats; Rats, Inbred Strains; Vasodilation | 1989 |
The endothelium and cyclic guanosine monophosphate in hyperthyroid-induced hypertension.
Topics: Acetylcholine; Animals; Biological Products; Cyclic GMP; Hydralazine; Hypertension; Hyperthyroidism; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Phenylephrine; Rats; Rats, Inbred Strains; Vasodilation | 1987 |
Augmentation of adenosine-induced relaxation response with hydralazine in aortic strips.
Topics: Adenosine; Animals; Aorta; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Drug Interactions; Hydralazine; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Rabbits | 1988 |
Effects of hydralazine and verapamil on phosphorylase activity and guanosine cyclic 3',5'-monophosphate levels in guinea-pig taenia coli.
Topics: Animals; Calcium; Colon; Cyclic GMP; Female; Guinea Pigs; Hydralazine; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Phosphorylases; Potassium; Verapamil | 1980 |
Characterization of the vasodilator action of antihypertensive drug budralazine.
Topics: Anesthesia; Animals; Antihypertensive Agents; Aorta, Thoracic; Cyclic AMP; Cyclic GMP; Dogs; Ear, External; Female; Hydralazine; Hypertension; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Potassium Chloride; Rabbits; Regional Blood Flow; Vasodilator Agents | 1983 |
Hypoxia modifies the vasodilatory effects of nitroglycerin, prostaglandin E1, and hydralazine on isolated porcine coronary arteries.
Topics: Alprostadil; Analysis of Variance; Animals; Coronary Vessels; Cyclic AMP; Cyclic GMP; Endothelins; Hydralazine; Hypoxia; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Swine | 1994 |
Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Bradykinin; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Hydralazine; Male; Nitric Oxide; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Wistar; Vasodilation | 1995 |
Cyclic guanosine 3',5' monophosphate concentrations in pre-eclampsia: effects of hydralazine.
Topics: Adult; Arginine; Birth Weight; Blood Pressure; Cyclic GMP; Female; Humans; Hydralazine; Nitric Oxide; Pre-Eclampsia; Pregnancy; Vasodilator Agents | 1996 |
Studies on endothelium-dependent vasorelaxation by hydralazine in porcine coronary artery.
Topics: Animals; Coronary Vessels; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Dactinomycin; Endothelium; Hemoglobins; Hydralazine; In Vitro Techniques; Indomethacin; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Protein Synthesis Inhibitors; Swine; Vasodilator Agents | 1997 |
Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzofurans; Blood Pressure; Cyclic GMP; Drug Interactions; Enalapril; Enzyme Inhibitors; Hydralazine; Hypertension; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Purinones; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 1997 |
Effect of atrial natriuretic peptide on electrical defibrillation efficacy.
Topics: Animals; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Electric Countershock; Electrocardiography; Hemodynamics; Hydralazine; Infusions, Intravenous; Treatment Outcome; Vasodilator Agents; Ventricular Fibrillation | 1998 |
L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arginine; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclic GMP; Endothelins; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydralazine; Hydrazines; Hypertension; In Vitro Techniques; Indomethacin; Male; Methacrylates; Natriuresis; Nitrates; Nitrites; Nitroprusside; Rats; Rats, Inbred Dahl; Renal Artery; Thromboxane A2; Vasoconstriction | 2001 |
Effects of hydrazine derivatives on vascular smooth muscle contractility, blood pressure and cGMP production in rats: comparison with hydralazine.
Topics: Animals; Blood Pressure; Cyclic GMP; Dose-Response Relationship, Drug; Hydralazine; Hydrazines; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Wistar | 2003 |
Hydralazine decreases sodium nitroprusside-induced rat aortic ring relaxation and increased cGMP production by rat aortic myocytes.
Topics: Animals; Aorta; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Hydralazine; Male; Multienzyme Complexes; Muscle Relaxation; Myocytes, Cardiac; NADH, NADPH Oxidoreductases; Nitric Oxide; Nitroprusside; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2005 |
Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
Topics: Angiotensin II; Animals; Captopril; Cardiomegaly; Cyclic GMP; Fibrosis; Gene Expression Regulation; Guanylate Cyclase; Heart Ventricles; Hydralazine; Hypertension; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Atrial Natriuretic Factor; Renin-Angiotensin System; Signal Transduction; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2007 |
Human atrial natriuretic peptide suppresses torsades de pointes in rabbits.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Natriuretic Factor; Calcium Channels, L-Type; Cyclic GMP; Disease Models, Animal; Electrocardiography; Humans; Hydralazine; Male; Methoxamine; Pyrimidinones; Rabbits; Sympathomimetics; Torsades de Pointes; Vasodilator Agents | 2008 |
Antihypertensive therapy increases tetrahydrobiopterin levels and NO/cGMP signaling in small arteries of angiotensin II-infused hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biopterins; Cyclic GMP; GTP Cyclohydrolase; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reserpine; Signal Transduction | 2011 |